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A B S T R A C T
Objective: To compare the amount of the dermatan sulfate glycosaminoglycan between male patients with Nyhus type II
inguinal hernias and subjects without inguinal hernia, aged between 20 and 40 years. Methods: Two groups were formed:
One with 15 male patients with Nyhus type II inguinal hernia and aged between 20 and 40 years with ASA risk I and II, and
a control group of ten individuals, also males between 20 and 40, who had died up to 24 h before. We excluded female
patients, diabetic patients with connective tissue disease, smokers and surgical risk ASA III and IV. We resected a sample of
1 cm² of the transversalis fascia in the middle of the inguinal trigone, and 1 cm² of the anterior sheath of the rectus
abdominis muscle in the groin for the quantification of dermatan sulfate glycosaminoglycans by densitometry after agarose
gel electrophoresis. Results: The amount of dermatan sulfate showed no statistically significant difference between
patients with inguinal hernia and individuals without inguinal hernia in both the transverse fascia (p = 0.108) and anterior
sheath of the rectus abdominis muscle (p = 0.292). Conclusion: There was no difference in the amount of the dermatan
sulfate glycosaminoglycan among patients with Nyhus type II inguinal hernias and subjects without inguinal hernia in adult
males.
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INTRODUCTION
The connective tissue is characterized by a cellularcomponent, whose the main cell is the fibroblast, and
an intercellular material called extracellular matrix. This, in
turn, consists of a ground substance and fibers. The ground
substance is made of complex glycosaminoglycans (GAGs)
and proteins that are currently referred to as proteoglycan
and a group of structural glycoproteins also called
multifunctional proteins. The fibers are represented by
collagen, elastic and reticular fibers1-3.
The extracellular matrix was stigmatized as just
a passive framework, which supported the tissues on an
inert way. Currently, it is recognized as a dynamic
environment in which tissues organize, exchange
information and differentiate4. In the extracellular matrix,
collagen fibers are responsible for tissue resistance, the
elastic fibers and proteoglycans by the elasticity, and
multifunctional proteins or glycoproteins by tissue
adhesiveness5.
The degeneration of collagen is reported by many
authors as the main factor in the genesis of inguinal hernia6-
10. The decrease in collagen I and increased in collagen III
in the dense connective tissue are weakening factors that
favor the emergence of hernia11.
There is very intense interaction between the
components of the connective tissue, to the point that
changes in one of these components disrupt its harmony,
compromising tissue function12-14.
The decorin proteoglycan with dermatan sulfate
glycosaminoglycan is crucial in fibrillogenesis and
arrangement of collagen fibers in the extracellular matrix
of the connective tissue. It is believed that decorin is a key
regulator of collagen fibrillogenesis and is associated, in its
disability, with the weakness of fascia, tendons and skin
fragility. The deficiency of decorin is also associated with
the Ehlers-Danlos syndrome15.
This study aims to quantify and compare the
dermatan sulfate glycosaminoglycans in the transversalis
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fascia and anterior sheath of the rectus abdominis between
male patients aged 20 to 40 years with inguinal hernia
Nyhus type II and those without an inguinal hernia.
METHODS
Casuistry
All patients were operated at the Department of
General Surgery of the St John Baptist Hospital of the School
of Medical Sciences of Volta Redonda. This study was
approved by the Ethics Committee at the Federal University
of São Paulo under No. CEP 1406/08.
Two groups were so arranged: group I – 15 male
patients, aged between 20 and 40 years, with Nyhus type
II inguinal hernia and risk ASA I and II; group II – control:
ten fresh male cadavers with period of death less than 24
hours, aged between 20 and 40 years, without inguinal
hernia. We excluded females, patients aged below 20 years
and over 40, diabetics, patients with connective tissue
disease, smokers and surgical risk ASA III, IV and V.
Collection procedures
During surgery to treat inguinal hernia in group I,
1 cm2 fragments were removed both from the transversalis
fascia in the middle portion of the inguinal triangle
(Hasselbach’s triangle) and from the corresponding anteri-
or sheath of the rectus abdominis muscle.
During the autopsy in group II, after assuring that
there was no inguinal hernia on either side, a fragment of
1 cm2 of the transversalis fascia of the inguinal triangle and
of the anterior sheath of the rectus abdominis muscle were
removed.
Extraction of glycosaminoglycans
The samples were washed in phosphate buffered
saline (PBS). After this process, they were shredded without
being separated, fixed in 100% acetone and refrigerated.
They were later taken to the laboratory of Molecular
Biology, Department of Biochemistry, Federal University of
São Paulo - Paulista Medical School (UNIFESP - EPM).
The fragments were removed from the acetone
and subjected to drying in an oven at 50° C, resulting in a
ketonic powder, which was individually weighed on an
analytical scale. The dry powder was subjected to proteolysis
by maxatase 4mg/ml (Sigma, St Louis, MO, USA) in 0.05
M Tris-HCl buffer, pH 8.0, 1M NaCl, in the proportion of
1g ketonic powder for each 20 ml of buffer, stirring. The
solution was kept overnight at 60° C. On ice, 90%
trichloroacetic acid was added to the 10% final
concentration for precipitation of nucleic acids and peptides
for 20 min at 4° C. Then the material was centrifuged at
5000r for 20 minutes at room temperature, the precipitate
being discarded. The supernatant was added to two volu-
mes of methanol for precipitation of glycosaminoglycans,
at 20° C (freezer) for 18 to 24 hours. A new 5000r
centrifugation was repeated for 20 minutes at room
temperature, discarding the supernatant. The precipitated
material containing GAGs was dried in an oven and re-
suspended in distilled water at a rate of 5mg ketonic powder
to 10ml of distilled water. Finally, the compounds were
identified by agarose gel electrophoresis and quantified by
densitometry16-18.
Identification and quantification of
glycosaminoglycans
Identification of sulfated glycosaminoglycans was
performed by comparing the electrophoretic migration of
the samples with those of known standards and purified.
These same standards were used for the quantitative
determination of compounds by densitometry at 525 nm.
We used the Quick Scan 2000 densitometer Win - Helena
Laboratories – Beaumont, Texas, USA – for this purpose.
The standards used were chondroitin sulfate
extracted from whale cartilage; dermatan sulfate extracted
from bovine intestinal mucosa; and bovine lung heparan
sulfate. All have been purified in the Laboratory of
Molecular Biology, UNIFESP.
Comparisons were made of the amount of
dermatan sulphate and total glycosaminoglycans between
transversalis fascia and anterior sheath of the rectus
abdominis muscle in the control group and the inguinal
hernia group separately. This was meant to assess if there
was a difference and if it was a localized or systemic change.
The second analysis was made in the transversalis
fascia to compare the amount of dermatan sulfate between
individuals with inguinal hernia and individuals without it.
Another analysis was performed to compare the amount
of dermatan sulfate in the anterior sheath of rectus
abdominis muscle in individuals with inguinal hernia and in
individuals without it.
Statistical analysis
We conducted the following statistical tests: a)
non-parametric test of Wilcoxon, used to compare two
dependent or paired samples; it was applied to compare
the amount of glycosaminoglycans between the locations
transversalis fascia and rectus abdominis’ sheath for the
same patients; b) nonparametric Mann-Whitney, used to
compare two independent samples; it was used to compa-
re the amount of glycosaminoglycans between individuals
with inguinal hernia and individuals without it. For all
statistical tests the level of significance was set at alpha
<0.05 or 5%.
RESULTS
There was no statistical difference between the
amount of dermatan sulphate and total glycosaminoglycans
in the transversalis fascia and anterior sheath of the rectus
abdominis musle in the groups separately (Table 1).
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There was no statistical difference between the
amount of dermatan sulphate and total glycosaminoglycans
in the transversalis fascia of patients with hernias and the
control group (Table 2).
There was no statistical difference between the
amount of dermatan sulphate and total glycosaminoglycans
in the sheath of the rectus abdominis muscel between the
control group and patients with hernia (Table 3).
DISCUSSION
The strong and significant interaction of
glycosaminoglycans with collagen fibrillogenesis is a widely
known fact.
In the dense connective tissue (fascia, tendons
and aponeurosis) there is a proteoglycan called decorin that
has, connected to its core protein, a single chain of
glycosaminoglycan, which may be more often a dermatan
sulfate or chondroitin sulfate. The proteoglycan decorin /
dermatan sulfate represents 90% of the proteoglycans in
the dense connective tissue and it is the one which has
greater ability to interfere with collagen fibrillogenesis by
inhibiting the radial growth of the fibril19,20.
Proteoglycans dermatan sulfate and chondroitin
sulfate interact strongly with collagen I, both through the
glycosaminoglycan chain and through the protein core,
inhibiting collagen fibrillogenesis21.
A study showing the interaction between
proteoglycans and collagen in rat tendon found that the
chondroitin sulfate proteoglycan is related to the formation
of thinner collagen fibers, present in immature tendons,
and that dermatan sulfate proteoglycan is related to the
thicker collagen fibers present in mature tendons. It also
demonstrated that the increase of chondroitin sulfate
proteoglycan leads to thinner collagen fibers, similar to what
happens with the corneal tissue. In the mature phase of
the tendon, the concentration of chondroitin sulfate
proteoglycan decreases and the one of dermatan sulfate
increases, leading to a predominance of thick fibers22.
Through an electron microscopy study
that examined the arrangement between the
glycosaminoglycans and collagen fibers in tendons, it was
found that the glycosaminoglycans are present on the
outside, around the collagen fibril, and not within it. It was
concluded that there is a strong and specific interaction
between glycosaminoglycans and collagen in the dense
connective tissue23.
Studies performed a breach in the gene
responsible for synthesis of proteoglycan decorin dermatan
Table 1 – Comparison of the amount of dermatam sulfate
between the transversalis fascia and anterior
sheath of the rectus abdominis muscle in groups
separately.
Dermatan Sulfate Without hernia With hernia
Sheath > fascia 6 8
Sheath <  fascia 4 7
P value 0.799 0.394
Wilcoxon test.
Table 2 - Comparison the amount of dermatam sulfate between control and inguinal hernia groups in the transversalis
fascia.
Gl icosaminoglycans Contro l  Hernia p value Mann-Whitney
Dermatam Sulfate 0.108
Average 3.6 2.9
Standard deviation 1.1 0.92
Min – max 1.86 – 5.18 1.41 – 5.07
Table 3 - Comparison of the amount of dermatam sulfate between the control group and patients with inguinal hernia in the
sheath of the rectus abdominis muscle.
Glycosaminoglycans Contro l  Hernia p value Mann-Whitney
Dermatam Sulfate 0.292
Average 4.07 3.16
Standard deviation 1.85 0.63
Min – max 2.11 – 7.97 1.74 – 4.12
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sulfate in rats, comparing them to a control group, founding
that rats with the absence of decorin had different diameters
and size of fibrils, alternating thick and thin fibers, opposite
to the uniformity found in the control group. They had also
irregularly shaped fibers, in contrast to the circular form of
the control group. These changes have an important
influence on the strength of the tissue. They concluded
that decorin plays a fundamental role in the formation and
ordering of collagen fibrils in the extracellular matrix, and
what changes it can result in alterations in the architecture
of the extracellular matrix, with consequent loss of tensile
function of the dense connective tissue15.
We know the importance of decorin dermatan
sulfate proteoglycan in fibrillogenesis and arrangement of
collagen fibers in the extracellular matrix and its consequent
role in tissue resistance. The core protein of proteoglycans
binds to collagen fibrils and the glycosaminoglycan chains
are connected with the chain of the neighboring
proteoglycan glycosaminoglycan. This arrangement gives
mobility to the glycosaminoglycan chains that can align
orthogonally or parallel to the long axis of collagen fibrils,
rearranging during stress, ensuring the mechanical
communication of the fibrils and distributing the received
strength throughout the tissue24,25.
Glycosaminoglycans have a key role in the
modulation of collagen fibrillogenesis and organization of
the extracellular matrix. It is hypothesized that because of
this close relationship and functional mechanics of
glycosaminoglycans with collagen, it would be possible, in
theory, that changes in concentration of glycosaminoglycans
might compromise the collagen fibers of the extracellular
matrix of the connective tissue of the transversalis fascia,
and therefore, cause the weakening of the tissue and
appearance of inguinal hernia.
When the pathogenesis of inguinal hernia is
studied, four factors must be analyzed: peritoniovaginal
conduct persistence, failure of the musculo-fascial defense
mechanisms of the inguinal canal, degeneration of
connective tissue and triggering factors.
The degeneration of connective tissue is the main
factor in the origin of inguinal hernia, a fact confirmed in
clinical practice with the use of prostheses for its treatment.
The use of prostheses, which in reality deals with connective
tissue disease, reduced the recurrence of inguinal hernia to
less than 1%26-28.
In the extracellular matrix of dense connective
tissue collagen is primarily responsible for tissue resistance.
However, the matrix does not have only a support function.
Today we know that it has complex roles, such as adhesion,
differentiation, division, migration and cellular recognition,
and information transmission between cells. There is intense
interaction and harmony among the members of the
extracellular matrix, and changing one component may
compromise the function of the other and therefore deter-
mine tissue functional loss4,12,29,30.
Recent studies on the pathogenesis of inguinal
hernia analyzed mainly collagen. With results still
controversial in humans, the alteration of the collagen fibers
is the main factor in the weakening of connective tissue,
but other components of the extracellular matrix could be
causing the change of collagen fibers. Studies point to this
fact by verifying changes in components of the extracellular
matrix other than the collagen fibers in patients with inguinal
hernia14. We then proposed to study, within the extracellular
matrix, the glycosaminoglycans dermatan sulfate
constituent of decorin proteoglycan, which has a primary
role in collagen fibrillogenesis, in a specific group of hernias,
Nyhus type II, and in younger individuals in which the effects
of the extracellular matrix degeneration are less evident.
Despite not finding statistically significant difference in the
amount of glycosaminoglycans between patients with
inguinal hernia and the control group, the role of
glycosaminoglycans in the extracellular matrix is not only
represented by their concentration. Changes in the
molecular structure, such as alterations in the site of
sulfation, for example, may also compromise their function31.
Thus, further studies are needed to clarify whether there is
change in the molecular structure of glycosaminoglycans
that could alter their function and thus collagen
fibrillogenesis.
The authors believe that for an individual to
develop indirect inguinal hernia it is necessary a
persistence of a patent peritoniovaginal conduct along
with failure of the defense mechanisms in the inguinal
canal, caused by the degeneration of the connective
tissue, which causes the abdominal contents to protrude
through the deep inguinal orifice, associated with
triggering factors, which are conditions that increase intra-
abdominal pressure.
In conclusion, there was no statistically significant
difference between the amount of the dermatan sulfate
glycosaminoglycan in men aged between 20 and 40 years
with Nyhus type II inguinal hernia and those without an
inguinal hernia.
R E S U M O
Objetivo: Comparar a quantidade do glicosaminoglicano dermatam sulfato  entre pacientes homens, portadores de hérnia inguinal
tipo II de Nyhus e, indivíduos sem hérnia inguinal, com idade entre 20 e 40 anos. Métodos: Foram constituídos dois grupos. Um de
15 pacientes do sexo masculino com hérnia inguinal tipo II de Nyhus e idade entre 20 e 40 anos, com risco ASA I e II, e um grupo
controle com dez indivíduos, também do sexo masculino entre 20 e 40 anos, que morreram em período de até 24 h. Foram excluídos
os pacientes do sexo feminino, diabéticos, portadores de doença do tecido conjuntivo, tabagistas e com risco cirúrgico ASA III e IV. Foi
retirada uma amostra de 1cm2 da fáscia transversal na parte intermediária do trígono inguinal, e 1cm2 na bainha anterior do músculo
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reto abdominal na região inguinal correspondente e quantificados os glicosaminoglicanos dermatam sulfato por densitometria, após
eletroforese em gel de agarose. Resultados: A quantidade de dermatam sulfato não apresentou diferença estatisticamente
significante entre os pacientes com hérnia inguinal e os indivíduos sem hérnia inguinal, tanto na fáscia transversal (p=0,108) quanto
na bainha anterior do músculo reto abdominal (p=0,292). Conclusão: Não se encontrou diferença na quantidade do  glicosaminoglicano
dermatam sulfato  entre os pacientes portadores de hérnia inguinal tipo II de Nyhus e indivíduos sem hérnia inguinal em homens
adultos.
Descritores: Glicosaminoglicano. Sulfato de dermatana. Matriz extracelular. Hérnia inguinal.
